With the global pandemic still in full swing, scientists are working to develop a vaccine in record time. While everyone wants an effective vaccine, they don’t all agree on how to get there and what “effective” really means. Chemical & Engineering News, the weekly news magazine of the American Chemical Society, spoke with researchers, doctors and business leaders to shed light on some of the challenges vaccine developers are facing. As of mid-July, the World Health Organization reported that over 160 vaccine programs were in progress, an unprecedented effort toward a common goal, writes Associate Editor Ryan Cross. Although traditional vaccines are made with weakened or killed virus, many modern vaccines use part of the virus itself to teach immune cells what to home in on. For SARS-CoV-2, the virus that causes COVID-19, that part is the spike protein, which the virus uses to attach itself to human cells. Both types of...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




